Cigna Group (NYSE: CI) is a global health services company that provides a wide range of insurance products and services. It operates through segments like Evernorth, which focuses on health services, and Cigna Healthcare, which offers insurance products. Cigna competes with other major health insurers like UnitedHealth Group and Anthem.
On November 5, 2025, Wells Fargo set a price target of $300 for CI, while the stock was trading at $264.66. This target suggests a potential upside of approximately 13.35%. However, CI's stock has faced challenges, particularly after its third-quarter 2025 earnings call, where it reported expected margin pressure in its pharmacy benefit services segment.
The announcement of margin pressure has contributed to a decline in CI's stock price. Currently, CI is trading at $264.14, down by 0.20% from the previous day. The stock has fluctuated between $257.70 and $266.15 today. Over the past year, CI has seen a high of $350 and a low of $239.51, indicating significant volatility.
In response to cost and transparency concerns, Evernorth, Cigna's health services division, introduced a rebate-free pharmacy benefit model. This model aims to reduce costs and improve transparency. Cigna Healthcare plans to implement this model for its fully insured lives by 2027, with full adoption by Evernorth clients by 2028.
Cigna is also focusing on improving the economic terms of contracts for long-term strategic clients, especially those involved in government programs. Despite these efforts, the company's market capitalization is approximately $70.56 billion, with a current trading volume of 690,780 shares on the NYSE.
